"Unlike everybody else, we feel we've go critical mass in all our businesses," so says Christopher Viehbach, CEO Sanofi. "Valuations are extremely high right now. I am very glad I did most of my M&A activity from 2009 to 2011. I am feeling great about what we have; I haven't felt this great in years."
Posted by Bruce Lehr June 6th 2014.